Related content

Cardiovascular Drug Therapy in the Elderly: Theoretical and Practical Considerations

By Williams B.R.  

Drugs & Aging, Vol. 20, Iss. 6, 2003-01 ,pp. : 445-463

Adis International

Access to resources Recommend Favorite

Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy

By Mango Ruggiero   Vecchione Lucia   Raso Barbara   Borgiani Paola   Brunetti Ercole   Mehta Jawahar L   Lauro Renato   Romeo Francesco   Novelli Giuseppe  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2565-2576

Informa Healthcare

Access to resources Recommend Favorite

Drug therapy for prevention of cardiovascular disease — should surrogate measures be abandoned?

By Winocour Peter H  

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 282-286

Royal College Of Physicians

Access to resources Recommend Favorite

Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers

By Guerin Christopher   Olivi Alessandro   Weingart Jon D.   Lawson H. Christopher   Brem Henry  

Investigational New Drugs, Vol. 22, Iss. 1, 2004-01 ,pp. : 27-37

Springer Publishing Company

Access to resources Recommend Favorite

SMI meeting: innovations in cardiovascular drugs

By Fitzgerald J.D.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 711-715

Informa Healthcare

Access to resources Recommend Favorite